https://doi.org/10.1038/srep04283
H
Honglian Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
1.8K
Citations
24
h-index
51
i10-index
Honglian Wang is an academic researcher from Yangtze University. The author has contributed to research in topics: Renal and related cancers & Chronic Kidney Disease and Diabetes & Renal Diseases and Glomerulopathies. The author has an h-index of 24, co-authored 81 publications.
ORCID: 0000-0003-1169-176XPapers by this author
worksThe Effect of microRNAs in the Regulation of Human CYP3A4: a Systematic Study using a Mathematical Model
2014 · Scientific Reports · 57 citations
Bacterial IgA protease-mediated degradation of agIgA1 and agIgA1 immune complexes as a potential therapy for IgA Nephropathy
2016 · Scientific Reports · 42 citations
https://doi.org/10.1038/srep30964
Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway
2018 · Phytotherapy Research · 35 citations
https://doi.org/10.1002/ptr.6184
Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease
2022 · Journal of Natural Medicines · 22 citations
https://doi.org/10.1007/s11418-022-01647-w
Mesenchymal stem cells transplantation combined with IronQ attenuates ICH-induced inflammation response via Mincle/syk signaling pathway
2023 · Stem Cell Research & Therapy · 16 citations
https://doi.org/10.1186/s13287-023-03369-6
Calycosin pretreatment enhanced the therapeutic efficacy of mesenchymal stem cells to alleviate unilateral ureteral obstruction-induced renal fibrosis by inhibiting necroptosis
2022 · Journal of Pharmacological Sciences · 14 citations
https://doi.org/10.1016/j.jphs.2022.12.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat